Quinaldopeptin, a new type of quinomycin antibiotic, was isolated from the culture of Streptoverticillium album strain Q132-6. The antibiotic exhibited strong in vitro antimicrobial and cytotoxic activity and significantly prolonged the survival time of mice inoculated with a murine tumor. Quinaldopeptin is a symmetric cyclic peptide linked only by peptide bonds and differs from known antibiotics of the quinomycin family by the lack of ester linkage.
In our search for microbial metabolites with antitumor activity, a novel antibiotic, quinaldopeptin has been isolated from the cultured broth of Streptoverticillium album strain Q132-6 which was isolated from a soil sample collected in AndhraPradesh, India. The antibiotic was recovered from the fermentation broth by solvent extraction and purified by chromatography. Structural studies combining spectral analysis and chemical degradation disclosed that quinaldopeptin is a symmetric cyclic peptide comprised of 2 mol each of 3-hydroxyquinaldic acid, glycine, sarcosine and a,/?-diaminobutyric acid and 4mol of pipecolic acid. Although quinaldopeptin should be classified in the quinomycin group of antibiotics, it distinctly differs from the known compounds by the lack of an ester linkage. Quinaldopeptin is highly active against Gram-positive bacteria and anaerobes and strongly cytotoxic against cultured B16melanomacells. It prolonged the survival time of mice transplanted with P388 leukemia. This paper describes the isolation, properties, structural determination and biological activities of quinaldopeptin.
Isolation of the Producing Organism An actinomycete, strain No. Q132-6, which produces quinaldopeptin along with aureothricin and a methylpentaene, was isolated from a soil sample collected in Andhra Pradesh State, India. Strain Q132-6 was identified as genus Streptoverticillium, and classified into S. album.
Taxonomy of the Producing Organism Morphology
Substrate mycelium is well-branched and appears non-fragmented in the intact colony. The formation of aerial mycelium is very poor. Short straight spore chains are borne on the biverticillate sporophores. The sporulation is limited to Czapek's sucrose -nitrate agar and ISP medium No. 9, supplemented with D-mannitol or someother sugar. Irregular tufty sporophores or verticils with scanty spores are often observed (Fig. 1) . The spore chains contain 2 to 10 spores per sporophore; the spores are oval or short-cylindrical (0.6 x 0.8~1.5 /mi), and have a smooth surface. A balloon-like body is occasionally formed, but motile spores, sporangia or true sclerotia were not observed. Quinaldopeptin was originally called as BMY-28662 or BU-3845T. Cultural and Physiological Characteristics Color of aerial mycelium is white, or occasionally white with yellow to grayish shades after long incubation. Yellowish diffusible pigment is produced in ISP media Nos. 3, 4, 5 and 7. Melanin and other distinct pigments are not produced (Table 1 ). The physiological characteristics of strain Q1 32-6 are shown inTable2. 
Taxonomic Position
The above-mentioned morphology and chemotaxonomy indicate that strain Q132-6 belongs in the genus Streptoverticillium.
According to the descriptions of the species by Baldacci and Locci1*, Shirling and Gottlieb2), and Williams et al. 3) , it is similar to Streptoverticillium ladakanum, Streptoverticillium morookaensis and S. album. Physiologically, Q132-6 differs slightly from the three species (Table 3) , but it is similar to S. album in aureothricin production and cultural characteristics.
Thus, strain Q132-6 was designated S. album. (Hokuyo Suisan), CaSO4-2H2O 0.6% and CaCO3 0.5% (pH7.0) in a 500-ml Erlenmeyer flask, and was incubated at 28°C for 4 days on a rotary shaker at 200rpm. Five ml of the culture was transferred into a 500-ml Erlenmeyer flask containing 100 ml of the production mediumhaving the same composition as the seed medium. The fermentation was carried out at 28°C for 5 days on a rotary shaker at 200 rpm. The fermentation study was also carried out in a jar fermenter. Five hundred ml of the seed culture prepared by the above method was transferred into a 20-liter jar fermenter containing 12 liters of the production medium as described 799 Table 3 . Differential characteristics of strain Q132-6 and three relevant species of Streptoverticillium. above. The jar fermenter was aerated at the rate of 12 liters per minute and agitated at 250rpmat 28°C. The antibiotic activity in the fermentation broth was monitored by the in vitro cytotoxic activity against cultured B16 melanoma cells using a microtiter plate. The harvested broth after 70-hour fermentation showed a potency of approximately 100 /zg/ml. Isolation and Purification The harvested broth (19 liters) was extracted with 16 liters of butanol at pH7.6. The extract was concentrated under reduced pressure and applied to a column of silica gel (Wako gel C-200, i.d. 4 .0 x 60 cm). The columnwas developed with a mixture of methanol and ethyl acetate with a stepwise increasing methanol concentration (0->20%). The eluate was monitored by the bioassay using Bacillus subtilis PCI 219 and by spot test of UVabsorption on TLC plates. The first bioactive, UV-absorbing fractions were eluted with ethyl acetate. Concentration of the pooled fractions afforded a yellow solid (895 mg) which was identified as aureothricin by its spectral data. The second active fractions eluted with 10%methanol were pooled and concentrated to give a semi-pure solid of quinaldopeptin (13.5g).
The solid was rechromatographed on a silica gel column (i.d. 4 .0 x 20cm) using a mixture of methanol and methylene chloride (methanol concentration 0->5%). After monitoring by bioassay and TLC (SiO2, chloroform -methanol, 10 : 1), the appropriate fractions were combined and evaporated. The residue was crystallized from a mkture of chloroform and ether to give colorless rods of pure quinaldopeptin (1.38 g).
Physico-chemical Properties
Physico-chemical properties of quinaldopeptin are summarized in Table 4 . It is soluble in pyridine and slightly soluble in dimethyl sulfoxide but insoluble in other organic solvents and water. This antibiotic showeda positive response to ferric chloride, but negative response to ninhydrin, anthrone and Sakaguchi reactions. The UVspectrum exhibited maxima at 214, 230, 299 and 359 nm in neutral and acidic solution and at 211 (sh), 222, 251, 307 (sh) and 396nm in alkaline solution. The IR spectrum (Fig. 2) had strong absorption bands at 3340, 3300 (OH and/or NH), 1690, 1645 and 1530cm"1 (amide). The molecular formula was determined to be C62H78N14O14on the basis of the microanalysis and SI-MS data (m/z 1 ,266 (M + Na)+ , 1 ,244 (M + H)+). Acetylation of quinaldopeptin with acetic anhydride and pyridine gave a diacetyl derivative with improved solubility, whose physico-chemical data are also shown in Table 3 . The SI-MS spectrum of diacetylquinaldopeptin gave quasi-molecular ions at m/z 1,350 (M +Na)+ and 1,328 (M + H)+, which accounted for introduction of two acetyl groups.
Structural Studies
Quinaldopeptin did not give clear signals in iH or 13C NMRspectra due to its extremely poor solubility in the NMRsolvents. The diacetyl derivative showed much improved solubility and the 13C NMRspectrum of the acetate exhibited a total of 33-carbons as summarizedin Table 5 . They were resolved as three methyl, ten methylene, four methine, nine sp2 (five with proton and four without proton) and seven carbonyl carbons. Taking into consideration the molecular formula (C66H82N14O16) determined as discussed above, the 13C NMRof diacetylquinaldopeptin suggested that the antibiotic consisted of two equivalent molecules. The UVspectrum of quinaldopeptin was almost identical to that of sandramycin4) indicating the same chromophore, 3-hydroxyquinaldic acid. The IR spectrum, however, lacked the ester absorption at 1730~1710cm" 1 which all other known echinomycin group antibiotics5~8) have.
Complete Acid Hydrolysis Quinaldopeptin was hydrolyzed with 6n HC1 at 110-120°C for 18 hours in a sealed tube. A yellow crystalline product (I) was collected by filtration. The IR and UV spectra and mp ofI were identical to those reported for 3-hydroxyquinaldic acid9). The filtrate was concentrated in vacuo and the residue was chromatographed on a column of Dowex 50WX8(H+ type) with hydrochloric acid elution. Four amino acids, glycine (II), sarcosine (III), pipecolic acid (IV) and a,/?-diaminobutyric acid (V) were isolated in a ratio of 1 : 1 :2: 1. The L-configuration was assigned to the pipecolic acid by its optical rotational value (Md -9.9°)1O). The NMRspectrum of the a,/?-diaminobutyric acid indicated that it was a mixture of the erythro and threo isomers. It is well recognized that a-amino group of a,/?-diaminobutyric acid is readily racemized in acid hydrolysisn). Therefore, quinaldopeptin is considered to have a,/?-diaminobutyric acid of single absolute configuration which racemized during the acid hydrolysis. Elucidation of the absolute configuration was performed by following reactions12). The a,/?-diaminobutyric acid obtained above was treated with hydrogen peroxide in the presence of ferrous sulfate to give alanine which was determined to be of "d" configuration by HPLCusing a chiral column. Therefore, the /7-carbon of the amino acid has^-configuration. For determination of the a-carbon configuration, compound VI, a partial hydrolysis product as will be discussed later, was deaminated with sodium nitrate under acidic condition. The product was then hydrolyzed to give a mixture of D-threonine and D-allo-threonine by chiral HPLC. Consequently, the absolute configuration of a,/?-diaminobutyric acid of quinaldopeptin is D-erythw.
Partial Degradation and Determination of the AminoAcid Sequence Quinaldopeptin was hydrolyzed with 3 n HC1 at 70°C for 18 hours. Six degradation products (VI, VII, VIII, IX, X and XI) retaining the UVspectrum of the parent antibiotic were isolated after chromatographic separation. Structure elucidation of these products was performed by further degradations and spectral analysis.
Compound VI (m/z 290 (M-t-H)+) produced I and V upon acid hydrolysis. In the 1H NMR, the amide NH of VI (S 9.37, d, /=8.1Hz) coupled with a-CH of V (<S 4.20) allowing the structure Afa-(3-hydroxyquinaldyl)-a,/?-diaminobutyric acid to be assigned to this compound. The mass spectrum (m/z 401 (M+H)+) and acid hydrolysis (I, IV and V) suggested 1 mol ofIV bonded to VI in compound VII. The site of linkage was assigned to the £-amino (3 8.30, d, /=8.5Hz) of V by the WHCOSY spectrum. Compound VIII (C23H29N5O6, m/z 472 (M+H)+) was similar to VII in spectral properties but, upon hydrolysis, produced amino acid III in addition to the three constituents of VII. In the *H NMRspectrum of VIII, the a-H of IV moiety was observed at 3 4.99, ca. 1.3ppm lower field than the corresponding proton of VII. This indicated that unlike that of VI and VII, the a-H of IV of VIII took the equatorial conformation upon the formation of the peptide linkage at the NHof IV with III. The conformational change and resulting chemical shift change of the a-H of pipecolic acid are well exemplified in the structural study of rapamycin13). The 13C NMRand mass spectra and complete hydrolysis established the molecular formula and constituents of compounds IX, (C22H27N5O6, 1, II, IV and V), X (C28H36N6O7, 1, II, 2 x IV and V) and XI (C31H41N7O8, 1, II, III, 2 x IV and V). Compound XI represented exactly half of the parent antibiotic. The above constituent analysis indicated that IX, X and XI corresponded to VI, VII and VIII, respectively, but possessed an additional 1 mol unit of II and IV. Therefore, II and IV should be linked through the carboxylic acid of V and the *H NMRof the corresponding protons supported this assignment. In order to determine the C-terminal amino acid, XI was Af-acetylated and then converted to the methyl ester (m/z 710, (M +H)+) which was treated with LiBH414). Acid hydrolysis of the reduction product gave I, III, IV and V but no trace ofII. Thus, the structures ofVI, VII, VIII, IX, X and XI were as shown in Fig. 3 which naturally established the structure of quinaldopeptin as Fig. 4 . Antimicrobial Activity The antimicrobial activity of quinaldopeptin was determined by the 2-fold agar dilution method using Nutrient Agar (Eiken) for Gram-positive and Gram-negative bacteria, Gifu Anaerobic Medium (Nissui) for anaerobic bacteria and Sabouraud dextrose agar for fungi. The antimicrobial spectra of quinaldopeptin and its acetate are shownin Table 6 . Both compoundsshowedstrong activity against aerobic Gram-positive bacteria as well as anaerobic Gram-positive bacteria, but they were less active against aerobic Gram-negative bacteria. Antifungal activity of both antibiotics was rather weak except for Cryptococcus neoformans.
Antitumor Activity Quinaldopeptin and diacetylquinaldopeptin were tested for in vitro cytotoxicity against murine and human tumor cells and for in vivo antitumor activity in mice. ChromomycinA3 (in vitro) or mitomycin C (in vivo) was used as a reference compound. JULY 1990 B16-F10 (murine melanoma) and Moser (human colorectal carcinoma) cells were grown in Eagle's minimum essential medium supplemented with fetal calf serum (10%) and kanamycin (60/jg/ml).
Exponentially growing cells were harvested, counted and suspended in the culture mediumat 2 x 104 and 5 x 104 cells/ml, respectively. After planting 1 50^1 of cell suspension into wells of a 96-well microtiter plate with test materials (50/il), the plates were incubated at 37°C in a humidified atmosphere of 5% CO2 and 95%air for 72 hours. The cytotoxicity against the tumor cells was colorimetrically determined at 540 nm after staining viable cells with neutral red solution. As shown in Table 7 , quinaldopeptin and diacetylquinaldopeptin were quite active against B16-F10 cells with IC50 values approximately 3-fold superior to that of chromomycin A3. On the other hand, they showed almost the same cytotoxicity as chromomycin A3 against Moser cells.
The in vivo antitumor activity of quinaldopeptin was examined against lymphocytic leukemia P388 in mice. P388 Leukemia was inoculated intraperitoneally into female CDFXmice at 106 cells per mouse and graded doses of test materials were administered intraperitoneally on days 1 to 3 (QlD x 3) or on days 1, 5 and 9 (Q4D x 3) after tumor implantation. Death or survival of the treated and non-treated animals was recorded daily during the observation period of 45 days and the median survival time (MST) was calculated for the test (T) and control (C) groups. A T/C value^125%is considered a Table 8 . Antitumor activity against P388 leukemia (ip). Boldface type indicates significant antitumor effect (T/C^125%).
Discussion
Quinaldopeptin is a novel antitumor antibiotic produced by S. album No. Q132-6. It is active against a variety of Gram-positive and Gram-negative bacteria, C. neoformans and various tumor cells and exerts an antitumor effect against P388 leukemia.
The structural studies disclosed that quinaldopeptin is a symmetric, cyclic chromopeptide similar to the equinomycin-luzopeptin group antibiotics. Since it contains 3-hydroxyquinaldic acid and pipecolic acid, quinaldopeptin is closely related to the Iuzopeptins5'15) and sandramycin4). However, the amino acid units of quinaldopeptin are linked only by peptide linkages, which distinguishes it from all previously described equinomycin-luzopeptin group antibiotics. These known antibiotics contain two D-serines which form two ester linkages in the core peptide rings. Quinaldopeptin contains two D-ery£/?r0-a,/?-diaminobutyric acids in place of the D-serine of the known antibiotics.
Experimental General MP's were determined on a Shibayama micro melting point apparatus and were not corrected. TLC was performed on silica gel plates (Kiesel gel 60F254, Merck). The IR and UV spectra were recorded on a Jasco IR-810 IR spectrophotometer and a Jasco UVIDEC-610Cspectrometer, respectively. The SI-MS and FAB-MSspectra were measured on a Hitachi M80Band Jeol JMS-AX505H mass spectrometer. The *H and 13C NMRspectra were recorded on a Jeol JMN-GX400 spectrometer or Varian FT80A spectrometer. Aminoacid analysis was carried out using the Waters PICO-TAGsystem.
Acetylation
A mixture of quinaldopeptin (51 mg), acetic anhydride (0.25ml) and dry pyridine (1 ml) was stirred at room temperature for 24 hours. The reaction mixture was diluted with ethyl acetate (30ml) and then successively washedwith dilute hydrochloric acid, water and saturated sodium chloride. The organic layer was dried over Na2SO4and evaporated in vacuo to give 60mg of white powder which was purified by Sephadex LH-20 column chlormatography (2 x 60cm) using methanol as the eluant to give the pure diacetate (51 mg).
Complete Acid Hydrolysis of Quinaldopeptin A suspension of quinaldopeptin (490mg) in 6n HC1 (20ml) was heated at 110-120°C for 18 hours in a sealed tube. After cooling, the reaction mixture was filtered to give 139 mg of pale yellow crystalline Identified as glycine by amino acid analysis, TLC and NMR. The Configuration of a,/?-Diaminobutyric Acid A mixture of a,£-diaminobutyric acid (13.2mg), 3% H2O2 (0.2ml) and FeSO4 (0.2mg) was heated at 50°C for 1 hour. The reaction mixture was diluted with water and passed through a column ofAmberlite IR-120 (H+ form). The column was eluted with In NH4OH.The eluate was monitored by TLC (BuOH-AcOH-H2O, 3 : 1 : 1). The fractions containing alanine were combined and evaporated to dryness to give D-alanine, which was determined by chiral HPLC (column: MCI-gel ODSIHV, 4.6 x 150mm, Mitsubishi Chemical Industries Limited, mobil phase: 2 mMA^TV-Dipropyl-L-alanine, 1 him copper acetate, pH 5.7, flow rate: 0.8 ml/minute, detection: UV230 nm L-Ala 6.60 minutes, D-Ala 4.73 minutes). A mixture of VI (lmg), 80% aqueous AcOH (0.1ml), 3n HC1 (0.1ml) and NaNO2 (2mg) was stirred at room temperature for 5 hours. After dilution with water, the reaction mixture was extracted with BuOH.The extract was evaporated in vacuo to give a yellow residue, which was hydrolyzed with 6n Partial Acid Hydrolysis A suspension of quinaldopeptin (500mg) in 3n HC1 (40ml) was heated at 70°C for 18 hours in a sealed tube. The reaction mixture was extracted with BuOHand the extract was concentrated in vacuo to give 430mg of sticky pale yellow residue. The residue was chromatographed on a silica gel column
